NICU
Afula, Israel
NCT Number: NCT02125201
Neonatal intensive care unit patients undergoes many painful procedures during their hospitalization. Effective pain control in such procedures as intubation, catheterization, central line insertion, chest tube insertion, etc. is an important part of treatment. Opioids administration is a common practice for acute pain prevention. Fentanyl is the preferred opioid due to it rapid onset and short duration of action.
Fentanyl may be given intravenously, transcutaneous transmucosal and intranasal. Intranasal administration is practiced for about 20 years. A rich vascular supply in a nose provides rapid absorption of the drug. This uninvasive root is now popular for pain prevention and treatment. There are about 20 trials with intranasal fentanyl administration to children from 6 month old to 18 years. The investigators did not find information about this way of administration in neonates.
In our pilot study the investigators want to check if intranasal administration of fentanyl is safe and effective in pain prevention in term and preterm neonates during invasive procedures and to compare it with intravenous route of administration.
Looking for future studies?
Notify MeUp to 3 month
All sexes
Interventional
Phase 4
Afula, Israel
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Term and preterm neonates that require invasive procedures (elective or semielective intubation, central line insertion , chest drain or abdominal drain)
Exclusion criteria
A neonate will recieve Fentanyl intranasal or intravenous 5 minutes before the procedure The nurse will check his pain scale If the pain scale will be more than 4 the neonate will recieve the second dose of Fentanyl
Other names: Beatryl
Time frame: before the intervention and till one our after intervention
HaEmek Medical Center, Israel
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03790098
Inflammation, Neurologic Manifestations
Ithaca, New York, United States
View Trial DetailsNCT07651774
Chewing Function, Low Level Laser Therapy
Islamabad, Federal, Pakistan
View Trial DetailsNCT07758556
External Root Resorption, Neurologic Manifestations
Islamabad, Punjab Province, Pakistan
View Trial DetailsNCT07251270
Anxiety, Anxiety Disorders
Yenişehir, Mersin, Turkey (Türkiye)
View Trial Details